Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 61559X104 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Biotechnology Value Fund L P
13D/A
|
19.7% |
6/29/2026
Event 6/25/2026
|
||
| Biotechnology Value Fund L P | 10.2% | |||
| BVF I GP LLC | 10.2% | |||
| Biotechnology Value Fund II LP | 8.1% | |||
| BVF II GP LLC | 8.1% | |||
| Biotechnology Value Trading Fund OS LP | 1.3% | |||
| BVF Partners OS Ltd. | 1.3% | |||
| BVF GP Holdings LLC | 18.4% | |||
| BVF Partners L P/IL | 19.7% | |||
| BVF Inc/IL | 19.7% | |||
| Lampert Mark N | 19.7% | |||
| Loy Spike | <0.1% | |||
|
Deep Track Capital, LP
13G/A
|
9.7% |
8/14/2026
Event 6/30/2026
|
||
| Deep Track Capital, LP | 9.7% | |||
| Deep Track Biotechnology Master Fund, Ltd. | 9.7% | |||
| David Kroin | 9.7% | |||
| T. Rowe Price Investment Management, Inc. 13G | 5.3% |
8/14/2026
Event 6/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (5) | ||||
| Price T Rowe Associates Inc /MD/ 13G/A | 4.7% |
5/14/2025
Event 3/31/2025
|
||
|
Cormorant Asset Management, LP
13G/A
|
4.4% |
8/14/2026
Event 6/30/2026
|
||
| Cormorant Asset Management, LP | 4.4% | |||
| Bihua Chen | 4.4% | |||
|
Avoro Capital Advisors LLC
13G/A
|
3.2% |
11/14/2025
Event 9/30/2025
|
||
| Avoro Capital Advisors LLC | 3.2% | |||
| Behzad Aghazadeh | 3.2% | |||
| Chen Bihua 13G/A | 3.1% |
10/1/2025
Event 9/30/2025
|
||
|
FMR LLC
13G/A
|
1.1% |
11/5/2025
Event 9/30/2025
|
||
| FMR LLC | 1.1% | |||
| Abigail P. Johnson | 1.1% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 224 k | $2.62 M |
| 2026 Q2 | 188 | 74.1 M | $1.47 B |
| 2026 Q1 | 161 | 63.3 M | $1.18 B |
| 2025 Q4 | 150 | 56.4 M | $743 M |
| 2025 Q3 | 174 | 37.6 M | $270 M |
| 2025 Q2 | 148 | 58.6 M | $2.77 B |
| 2025 Q1 | 154 | 60.1 M | $2.35 B |
| 2024 Q4 | 131 | 63.2 M | $3.42 B |
| 2024 Q3 | 119 | 62.1 M | $3.13 B |
| 2024 Q2 | 129 | 61.6 M | $2.71 B |
| 2024 Q1 | 141 | 59.9 M | $3.01 B |
| 2023 Q4 | 156 | 59.8 M | $3.56 B |
| 2023 Q3 | 136 | 56.5 M | $3.22 B |
| 2023 Q2 | 87 | 56.3 M | $2.87 B |
| 2023 Q1 | 44 | 39.4 M | $843 M |
| 2022 Q4 | 34 | 37.7 M | $396 M |
| 2022 Q3 | 25 | 36.9 M | $291 M |
| 2022 Q2 | 24 | 36.5 M | $190 M |
| 2022 Q1 | 1 | 654 k | $7.26 M |